The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 31, 2021
Filed:
Jan. 05, 2018
Applicant:
Immusoft Corporation, Seattle, WA (US);
Inventors:
R. Scott McIvor, St. Louis Park, MN (US);
Perry B. Hackett, Shoreview, MN (US);
Jason Bell, Maple Grove, MN (US);
Myra Christine Urness-Rusten, Plymouth, MN (US);
Elena Aronovich, Lauderdale, MN (US);
David W. Hunter, Minneapolis, MN (US);
Assignee:
IMMUSOFT CORPORATION, Seattle, WA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 47/02 (2006.01); A61K 31/353 (2006.01); A61K 31/663 (2006.01); A61K 33/00 (2006.01); A61K 9/00 (2006.01); A61K 38/18 (2006.01); A61K 38/37 (2006.01); A61K 38/48 (2006.01);
U.S. Cl.
CPC ...
A61K 47/02 (2013.01); A61K 9/0019 (2013.01); A61K 31/353 (2013.01); A61K 31/663 (2013.01); A61K 33/00 (2013.01); A61K 38/1816 (2013.01); A61K 38/37 (2013.01); A61K 38/4846 (2013.01); A61K 48/0008 (2013.01); A61K 48/0075 (2013.01); A61K 48/0083 (2013.01);
Abstract
Materials and methods for treating a patient to express a therapeutic agent comprising administering a Kupffer cell-suppressing substance in combination with a vehicle for introducing, into the patient, an exogenous nucleic acid comprising a sequence for expression of the agent.